Billionaire Profile
Fernando Espinosa Abdalá
Global Rank
#2429

Image: Unsplash Contributor | Unsplash License | via Unsplash

Fernando Espinosa Abdalá

CEO, Pharmaceuticals
MEXICO
Real-Time Net Worth
$1.575B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
0% (24h)
Age
76
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
MEXICO

Biography

Fernando Espinosa Abdalá, born in the 1950s, is a Mexican billionaire whose wealth originates from the pharmaceuticals industry. His current net worth is estimated at $1.57 billion. Abdalá, along with his brother, derived a significant portion of his wealth from the sale of their pharmaceutical company, Rimsa, which they sold to Teva Pharmaceuticals in 2016 for $2.3 billion. Fernando was the operational president of the company before its sale. He currently ranks #2420 globally among billionaires and #19 in Mexico. Despite his significant wealth, Espinosa Abdalá maintains a low public profile.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Information about Fernando Espinosa Abdalá's early life and education is limited due to his preference for privacy. However, it is known that he was born in Mexico in the 1950s.

Rise to Success

Fernando Espinosa Abdalá's career took off within the pharmaceutical industry. His father founded a pharmaceutical distribution company in 1970, which later expanded into manufacturing. Fernando, along with his brother Leopoldo, played a pivotal role in growing the business, known as Representaciones e Investigaciones Médicas (Rimsa). Rimsa became a prominent pharmaceutical manufacturer and distributor in Mexico. The Espinosa Abdalá brothers' leadership and strategic decisions were crucial to Rimsa's success, including the development and patenting of new medicines.

Key Business Strategies

The key to Abdalá's success was the 2016 sale of Rimsa to Teva Pharmaceutical Industries for $2.3 billion. Before the sale, Rimsa was a major supplier of pharmaceutical products in Mexico, generating annual revenues exceeding $200 million. Following the acquisition, Teva initially planned to leverage Rimsa's infrastructure. After the sale, Teva sued Fernando and Leopoldo, alleging fraud and breach of contract. Although most charges were dismissed, the breach of contract was settled for less than $200 million.

Philanthropy

There is limited information available about Fernando Espinosa Abdalá's specific philanthropic activities. However, his company, PiSA Farmacéutica, is recognized as a Socially Responsible Enterprise (ESR) and has received the ESR Distinction from the Mexican Center for Philanthropy (Cemefi) for 14 consecutive years.

Career Milestones

1970

Founded Pharmaceutical Company

Fernando's father founded a pharmaceutical distribution company, the precursor to Rimsa, which would later become a major source of the Espinosa Abdalá's wealth.

2016

Sale of Rimsa

Fernando and his brother sold Rimsa to Teva Pharmaceutical Industries for $2.3 billion, marking a significant event in their business career.

Philanthropy & Social Impact

Corporate Social Responsibility

Socially Responsible Enterprise (ESR)

Undisclosed

PiSA Farmacéutica, the company associated with Espinosa Abdalá, has been recognized as a Socially Responsible Enterprise (ESR) and has received the ESR Distinction from the Mexican Center for Philanthropy (Cemefi) for 14 consecutive years.